Now showing items 1-1 of 1

    • Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma 

      Rini, Brian I.; McDermott, David F.; Hammers, Hans; Bro, William; Bukowski, Ronald M.; Faba, Bernard; Faba, Jo; Figlin, Robert A.; Hutson, Thomas; Jonasch, Eric; Joseph, Richard W.; Leibovich, Bradley C.; Olencki, Thomas; Pantuck, Allan J.; Quinn, David I.; Seery, Virginia; Voss, Martin H.; Wood, Christopher G.; Wood, Laura S.; Atkins, Michael B. (BioMed Central, 2016)
      Immunotherapy has produced durable clinical benefit in patients with metastatic renal cell cancer (RCC). In the past, patients treated with interferon-alpha (IFN) and interleukin-2 (IL-2) have achieved complete responses, ...